I-MAB SPONS.ADS/1 -0001 Cash Flow Conversion Efficiency

Latest as of December 2025: -0.063x

I-MAB SPONS.ADS/1 -0001 cash flow conversion efficiency. Based on the latest financial reports, I-MAB SPONS.ADS/1 -0001 (0VY) has a cash flow conversion efficiency ratio of -0.063x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-14.60 Million ≈ $-17.06 Million USD) by net assets (€230.94 Million ≈ $269.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of I-MAB SPONS.ADS/1 -0001 (2021–2025)

Cash flow conversion efficiency of I-MAB SPONS.ADS/1 -0001 from 2021 to 2025. This chart illustrates how I-MAB SPONS.ADS/1 -0001's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for I-MAB SPONS.ADS/1 -0001 for real-time trading data and today's change.

I-MAB SPONS.ADS/1 -0001 Cash Flow Conversion Ratio Explained

I-MAB SPONS.ADS/1 -0001 cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

I-MAB SPONS.ADS/1 -0001 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of I-MAB SPONS.ADS/1 -0001 ranked by their cash flow conversion efficiency. Also see 0VY stock market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Pantech Group Holdings Bhd KLSE:5125	-0.017x
Forth Smart Service Public Company Limited BK:FSMART	0.073x
THE REJECT SHOP LTD F:RFD	N/A
AIRO Group Holdings, Inc. Common Stock NASDAQ:AIRO	-0.008x
Seoul Broadcasting System KO:034120	0.012x
Userjoy Technology Co Ltd TWO:3546	0.066x
Warehouses Estates Belgium SCA BR:WEB	0.031x
Cystech Electronics Corp TWO:6651	0.066x

Annual Cash Flow Conversion Efficiency for I-MAB SPONS.ADS/1 -0001 (2021–2025)

The table below shows the annual cash flow conversion efficiency of I-MAB SPONS.ADS/1 -0001 from 2021 to 2025. Review free cash flow generation of I-MAB SPONS.ADS/1 -0001 to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€230.94 Million ≈ $269.99 Million	€-20.60 Million ≈ $-24.08 Million	-0.089x	+65.94%
2024-12-31	€201.16 Million ≈ $235.18 Million	€-52.67 Million ≈ $-61.58 Million	-0.262x	+12.63%
2023-12-31	€242.58 Million ≈ $283.61 Million	€-72.70 Million ≈ $-84.99 Million	-0.300x	-154.92%
2022-12-31	€421.77 Million ≈ $493.09 Million	€-49.58 Million ≈ $-57.97 Million	-0.118x	+44.92%
2021-12-31	€715.33 Million ≈ $836.29 Million	€-152.66 Million ≈ $-178.48 Million	-0.213x	--

About I-MAB SPONS.ADS/1 -0001

F:0VY Germany Biotechnology

Market Cap

$141.97 Million

€121.43 Million EUR

Market Cap Rank

#17690 Global

#1658 in Germany

Share Price

€1.05

Change (1 day)

-1.87%

52-Week Range

€1.05 - €4.46

All Time High

€70.00